BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+22.37%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$3.64B
AUM Growth
+$3.64B
Cap. Flow
-$639M
Cap. Flow %
-17.56%
Top 10 Hldgs %
62.29%
Holding
72
New
2
Increased
4
Reduced
13
Closed
10

Top Buys

1
CGON icon
CG Oncology
CGON
$82.7M
2
TYRA icon
Tyra Biosciences
TYRA
$31.5M
3
IMUX icon
Immunic
IMUX
$11.8M
4
ALLK
Allakos
ALLK
$10.1M
5
UNCY icon
Unicycive Therapeutics
UNCY
$2.06M

Top Sells

1
AXSM icon
Axsome Therapeutics
AXSM
$158M
2
MRUS icon
Merus
MRUS
$71.2M
3
CNTA
Centessa Pharmaceuticals
CNTA
$69.8M
4
JANX icon
Janux Therapeutics
JANX
$62.5M
5
PTGX icon
Protagonist Therapeutics
PTGX
$57.5M

Sector Composition

1 Healthcare 99.86%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ANTX icon
51
AN2 Therapeutics
ANTX
$33.9M
$4.03M 0.11%
1,239,470
-324,493
-21% -$1.05M
KRON
52
DELISTED
Kronos Bio
KRON
$3.78M 0.1%
2,905,043
– –
PVLA
53
Palvella Therapeutics, Inc. Common Stock
PVLA
$581M
$3.78M 0.1%
20,609,863
– –
VIRX
54
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.69M 0.1%
3,614,662
– –
IVA
55
Inventiva
IVA
$793M
$2.48M 0.07%
686,040
– –
FBRX icon
56
Forte Biosciences
FBRX
$136M
$2.09M 0.06%
2,982,105
– –
MOLN
57
Molecular Partners
MOLN
$139M
$1.72M 0.05%
443,221
– –
MTEM
58
DELISTED
Molecular Templates, Inc.
MTEM
$1.17M 0.03%
522,238
-9,800
-2% -$22K
NLSP icon
59
NLS Pharmaceutics
NLSP
$10.1M
$1.04M 0.03%
5,747,126
– –
ASLN
60
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$646K 0.02%
1,049,999
– –
CRVS icon
61
Corvus Pharmaceuticals
CRVS
$422M
$643K 0.02%
361,406
-1,009,541
-74% -$1.8M
RZLT icon
62
Rezolute
RZLT
$628M
$487K 0.01%
190,815
– –
RAIN
63
DELISTED
Rain Oncology Inc. Common Stock
RAIN
– –
-3,526,729
Closed -$4.23M
XENE icon
64
Xenon Pharmaceuticals
XENE
$2.99B
– –
-890,072
Closed -$41M
SYRE icon
65
Spyre Therapeutics
SYRE
$1.01B
– –
-687,080
Closed -$14.8M
STRO icon
66
Sutro Biopharma
STRO
$83.1M
– –
-3,347,946
Closed -$14.4M
SLN
67
Silence Therapeutics
SLN
$234M
– –
-1,508,416
Closed -$26.2M
RLAY icon
68
Relay Therapeutics
RLAY
$697M
– –
-3,970,045
Closed -$43.7M
ITOS
69
DELISTED
iTeos Therapeutics
ITOS
– –
-1,259,476
Closed -$13.8M
IMVT icon
70
Immunovant
IMVT
$2.85B
– –
-300,000
Closed -$12.6M
CNTA
71
Centessa Pharmaceuticals
CNTA
$2.08B
– –
-8,774,570
Closed -$69.8M
AXSM icon
72
Axsome Therapeutics
AXSM
$6.07B
– –
-1,981,100
Closed -$158M
1 2
3